Show simple item record

dc.contributor.authorBilehjani, E
dc.contributor.authorKianfar, AA
dc.contributor.authorToofan, M
dc.contributor.authorFakhari, S
dc.date.accessioned2018-08-26T06:33:13Z
dc.date.available2018-08-26T06:33:13Z
dc.date.issued2008
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/43639
dc.description.abstractPatients with peripartum cardiomyopathy may require analgesia/anesthesia for delivery or cesarean section. Many different methods of anesthesia has been used for this purpose. Remifentanil was used safely in peripartum cardiomyopathic patients, but there is not any report about etomidate usage in such patients. We report on a 19 years old patient, at 32 weeks of gestation, with severe peripartum cardiomyopathy, in uncompensated heart failure and pulmonary edema. She was scheduled for emergency cesarean section becaue of threatening mother's life and fetal distress. General anesthesia was induced with etomidate and maintained with remifentanil infusion safely, without any adverse outcome on mother or newborn.
dc.language.isoEnglish
dc.relation.ispartofMiddle East journal of anaesthesiology
dc.subjectAdult
dc.subjectAnesthesia, General
dc.subjectAnesthesia, Obstetrical
dc.subjectAnesthetics, Intravenous
dc.subjectCardiomyopathies
dc.subjectCesarean Section
dc.subjectEmergency Service, Hospital
dc.subjectEtomidate
dc.subjectFemale
dc.subjectHumans
dc.subjectPiperidines
dc.subjectPregnancy
dc.titleAnesthesia with etomidate and remifentanil for cesarean section in a patient with severe peripartum cardiomyopathy--a case report.
dc.typearticle
dc.citation.volume19
dc.citation.issue5
dc.citation.spage1141
dc.citation.epage9
dc.citation.indexPubmed


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record